---
document_datetime: 2025-12-29 08:02:15
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/vibativ-0.html
document_name: vibativ-0.html
version: success
processing_time: 0.1284896
conversion_datetime: 2025-12-31 02:02:14.522111
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Vibativ

[RSS](/en/individual-human-medicine.xml/65968)

##### Withdrawn

This medicine's authorisation has been withdrawn

telavancin Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Vibativ](#news-on)
- [More information on Vibativ](#more-information-on-vibativ-1162)
- [More information on Vibativ](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

The marketing authorisation for Vibativ has been withdrawn at the request of the marketing authorisation holder.

Vibativ : EPAR - Summary for the public

Reference Number: EMA/425452/2011

English (EN) (553.83 KB - PDF)

**First published:** 28/09/2011

**Last updated:** 16/05/2018

[View](/en/documents/overview/vibativ-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-484)

български (BG) (634.53 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/bg/documents/overview/vibativ-epar-summary-public_bg.pdf)

español (ES) (549.37 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/es/documents/overview/vibativ-epar-summary-public_es.pdf)

čeština (CS) (617.26 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/cs/documents/overview/vibativ-epar-summary-public_cs.pdf)

dansk (DA) (547.17 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/da/documents/overview/vibativ-epar-summary-public_da.pdf)

Deutsch (DE) (552 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/de/documents/overview/vibativ-epar-summary-public_de.pdf)

eesti keel (ET) (546.46 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/et/documents/overview/vibativ-epar-summary-public_et.pdf)

ελληνικά (EL) (639.48 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/el/documents/overview/vibativ-epar-summary-public_el.pdf)

français (FR) (550.8 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/fr/documents/overview/vibativ-epar-summary-public_fr.pdf)

hrvatski (HR) (1.06 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/hr/documents/overview/vibativ-epar-summary-public_hr.pdf)

italiano (IT) (548.98 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/it/documents/overview/vibativ-epar-summary-public_it.pdf)

latviešu valoda (LV) (616.63 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/lv/documents/overview/vibativ-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (577.48 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/lt/documents/overview/vibativ-epar-summary-public_lt.pdf)

magyar (HU) (610.46 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/hu/documents/overview/vibativ-epar-summary-public_hu.pdf)

Malti (MT) (620.67 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/mt/documents/overview/vibativ-epar-summary-public_mt.pdf)

Nederlands (NL) (547.6 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/nl/documents/overview/vibativ-epar-summary-public_nl.pdf)

polski (PL) (615.07 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/pl/documents/overview/vibativ-epar-summary-public_pl.pdf)

português (PT) (549.16 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/pt/documents/overview/vibativ-epar-summary-public_pt.pdf)

română (RO) (576.09 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/ro/documents/overview/vibativ-epar-summary-public_ro.pdf)

slovenčina (SK) (617.05 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sk/documents/overview/vibativ-epar-summary-public_sk.pdf)

slovenščina (SL) (568.91 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sl/documents/overview/vibativ-epar-summary-public_sl.pdf)

Suomi (FI) (547.15 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/fi/documents/overview/vibativ-epar-summary-public_fi.pdf)

svenska (SV) (548.33 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sv/documents/overview/vibativ-epar-summary-public_sv.pdf)

## Product information

Vibativ : EPAR - Product Information

English (EN) (989.46 KB - PDF)

**First published:** 28/09/2011

**Last updated:** 16/05/2018

[View](/en/documents/product-information/vibativ-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-18)

български (BG) (1.66 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/bg/documents/product-information/vibativ-epar-product-information_bg.pdf)

español (ES) (972.49 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/es/documents/product-information/vibativ-epar-product-information_es.pdf)

čeština (CS) (1.37 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/cs/documents/product-information/vibativ-epar-product-information_cs.pdf)

dansk (DA) (998.7 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/da/documents/product-information/vibativ-epar-product-information_da.pdf)

Deutsch (DE) (1012.89 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/de/documents/product-information/vibativ-epar-product-information_de.pdf)

eesti keel (ET) (990.29 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/et/documents/product-information/vibativ-epar-product-information_et.pdf)

ελληνικά (EL) (1.7 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/el/documents/product-information/vibativ-epar-product-information_el.pdf)

français (FR) (1.03 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/fr/documents/product-information/vibativ-epar-product-information_fr.pdf)

hrvatski (HR) (1014.8 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/hr/documents/product-information/vibativ-epar-product-information_hr.pdf)

íslenska (IS) (985.54 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/is/documents/product-information/vibativ-epar-product-information_is.pdf)

italiano (IT) (1.03 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/it/documents/product-information/vibativ-epar-product-information_it.pdf)

latviešu valoda (LV) (1.41 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/lv/documents/product-information/vibativ-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1023.66 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/lt/documents/product-information/vibativ-epar-product-information_lt.pdf)

magyar (HU) (1.37 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/hu/documents/product-information/vibativ-epar-product-information_hu.pdf)

Malti (MT) (1.44 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/mt/documents/product-information/vibativ-epar-product-information_mt.pdf)

Nederlands (NL) (1016.54 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/nl/documents/product-information/vibativ-epar-product-information_nl.pdf)

norsk (NO) (343.48 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/no/documents/product-information/vibativ-epar-product-information_no.pdf)

polski (PL) (1.45 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/pl/documents/product-information/vibativ-epar-product-information_pl.pdf)

português (PT) (1004.82 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/pt/documents/product-information/vibativ-epar-product-information_pt.pdf)

română (RO) (1.06 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/ro/documents/product-information/vibativ-epar-product-information_ro.pdf)

slovenčina (SK) (1.39 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sk/documents/product-information/vibativ-epar-product-information_sk.pdf)

slovenščina (SL) (1.39 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sl/documents/product-information/vibativ-epar-product-information_sl.pdf)

Suomi (FI) (983.01 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/fi/documents/product-information/vibativ-epar-product-information_fi.pdf)

svenska (SV) (1002.26 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sv/documents/product-information/vibativ-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0031 08/09/2017

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Vibativ   : EPAR - All Authorised presentations

English (EN) (469.33 KB - PDF)

**First published:** 28/09/2011

**Last updated:** 16/05/2018

[View](/en/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-906)

български (BG) (529.08 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/bg/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_bg.pdf)

español (ES) (485.69 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/es/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_es.pdf)

čeština (CS) (529.3 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/cs/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (485.73 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/da/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (484.5 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/de/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (485.88 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/et/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (528.76 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/el/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_el.pdf)

français (FR) (484.57 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/fr/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (492.6 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/hr/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (484.25 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/is/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_is.pdf)

italiano (IT) (503.04 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/it/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (526.53 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/lv/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (502.59 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/lt/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (508.09 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/hu/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (522.89 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/mt/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (485.68 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/nl/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (469.96 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/no/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_no.pdf)

polski (PL) (523.08 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/pl/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_pl.pdf)

português (PT) (485.04 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/pt/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_pt.pdf)

română (RO) (509.16 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/ro/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (540.33 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sk/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (507.44 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sl/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (488.95 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/fi/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (485.59 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sv/documents/all-authorised-presentations/vibativ-epar-all-authorised-presentations_sv.pdf)

Vibativ   : EPAR - Conditions imposed on member states for safe and effective use

English (EN) (618.72 KB - PDF)

**First published:** 28/09/2011

**Last updated:** 16/05/2018

[View](/en/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_en.pdf)

[Other languages (21)](#file-language-dropdown-455)

български (BG) (700.28 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/bg/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_bg.pdf)

español (ES) (613.31 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/es/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_es.pdf)

čeština (CS) (1.19 MB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/cs/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_cs.pdf)

dansk (DA) (614.54 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/da/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_da.pdf)

Deutsch (DE) (617.65 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/de/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_de.pdf)

eesti keel (ET) (617.52 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/et/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_et.pdf)

ελληνικά (EL) (697.34 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/el/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_el.pdf)

français (FR) (618.22 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/fr/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_fr.pdf)

italiano (IT) (619.69 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/it/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_it.pdf)

latviešu valoda (LV) (660.48 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/lv/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_lv.pdf)

lietuvių kalba (LT) (634.24 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/lt/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_lt.pdf)

magyar (HU) (647.41 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/hu/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_hu.pdf)

Malti (MT) (768.5 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/mt/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_mt.pdf)

Nederlands (NL) (613.46 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/nl/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_nl.pdf)

polski (PL) (699.38 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/pl/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_pl.pdf)

português (PT) (625.07 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/pt/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_pt.pdf)

română (RO) (643.04 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/ro/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_ro.pdf)

slovenčina (SK) (679.65 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sk/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_sk.pdf)

slovenščina (SL) (744.22 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sl/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_sl.pdf)

Suomi (FI) (606.41 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/fi/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_fi.pdf)

svenska (SV) (612 KB - PDF)

**First published:**

28/09/2011

**Last updated:**

16/05/2018

[View](/sv/documents/conditions-member-states/vibativ-epar-conditions-imposed-member-states-safe-and-effective-use_sv.pdf)

## Product details

Name of medicine Vibativ Active substance telavancin International non-proprietary name (INN) or common name telavancin Therapeutic area (MeSH)

- Pneumonia, Bacterial
- Cross Infection

Anatomical therapeutic chemical (ATC) code J01XA03

### Pharmacotherapeutic group

Antibacterials for systemic use

### Therapeutic indication

Vibativ is indicated for the treatment of adults with nosocomial pneumonia including ventilator-associated pneumonia, known or suspected to be caused by methicillin-resistant *Staphylococcus aureus* (MRSA).

Vibativ should be used only in situations where it is known or suspected that other alternatives are not suitable.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

## Authorisation details

EMA product number EMEA/H/C/001240 Marketing authorisation holder

Theravance Biopharma Ireland Umited

Connaught House 1

Marketing authorisation issued 02/09/2011 Revision 10

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Vibativ   : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (621.87 KB - PDF)

**First published:** 21/08/2012

**Last updated:** 16/05/2018

[View](/en/documents/procedural-steps-after/vibativ-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Vibativ-H-C-1240-A20-01 : EPAR - Assessment Report - Article 20

Adopted

Reference Number: EMA/303395/2012

English (EN) (750.45 KB - PDF)

**First published:** 21/08/2012

**Last updated:** 16/05/2018

[View](/en/documents/variation-report/vibativ-h-c-1240-a20-01-epar-assessment-report-article-20_en.pdf)

## Initial marketing authorisation documents

Vibativ   : EPAR - Public assessment report

Adopted

English (EN) (3.42 MB - PDF)

**First published:** 28/09/2011

**Last updated:** 16/05/2018

[View](/en/documents/assessment-report/vibativ-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Vibativ

Adopted

Reference Number: EMA/CHMP/399709/2011

English (EN) (649.04 KB - PDF)

**First published:** 19/05/2011

**Last updated:** 16/05/2018

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-vibativ_en.pdf)

#### News on Vibativ

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 February 2012](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-13-16-february-2012) 17/02/2012

[European Medicines Agency gives final recommendations for 12 centrally authorised medicines manufactured at Ben Venue Laboratories](/en/news/european-medicines-agency-gives-final-recommendations-12-centrally-authorised-medicines-manufactured-ben-venue-laboratories) 16/02/2012

[European Medicines Agency recommends precautionary recall of remaining batch of Vistide manufactured at Ben Venue Laboratories](/en/news/european-medicines-agency-recommends-precautionary-recall-remaining-batch-vistide-manufactured-ben-venue-laboratories) 13/12/2011

[European Medicines Agency gives further interim recommendations on dealing with shortcomings in quality assurance at Ben Venue Laboratories](/en/news/european-medicines-agency-gives-further-interim-recommendations-dealing-shortcomings-quality-assurance-ben-venue-laboratories) 09/12/2011

[European Medicines Agency gives interim recommendations to deal with shortcomings in quality assurance at Ben Venue Laboratories](/en/news/european-medicines-agency-gives-interim-recommendations-deal-shortcomings-quality-assurance-ben-venue-laboratories) 22/11/2011

#### More information on Vibativ

Public statement on Vibativ: Withdrawal of the marketing authorisation in the European Union

Reference Number: EMA/198910/2018

English (EN) (65.8 KB - PDF)

**First published:** 16/05/2018

**Last updated:** 16/05/2018

[View](/en/documents/public-statement/public-statement-vibativ-withdrawal-marketing-authorisation-european-union_en.pdf)

Final recommendations on 12 centrally authorised medicines manufactured at Ben Venue Laboratories

Reference Number: EMA/106872/2012

English (EN) (188.14 KB - PDF)

**First published:** 16/02/2012

**Last updated:** 22/02/2012

[View](/en/documents/medicine-qa/final-recommendations-12-centrally-authorised-medicines-manufactured-ben-venue-laboratories_en.pdf)

Questions and answers on shortcomings in quality assurance at Ben Venue Laboratories

Reference Number: EMA/946321/2011

English (EN) (71.91 KB - PDF)

**First published:** 13/12/2011

**Last updated:** 13/12/2011

[View](/en/documents/medicine-qa/questions-and-answers-shortcomings-quality-assurance-ben-venue-laboratories_en.pdf)

#### More information on Vibativ

- [EMEA-000239-PIP01-08-M03 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000239-pip01-08-m03)
- [A Post-Authorization Safety Study of the Use of Intravenous Telavancin (VIBATIV®) in the Clinical Setting (Telavancin PASS) - post-authorisation study](https://catalogues.ema.europa.eu/study/9670)

**This page was last updated on** 16/05/2018

## Share this page

[Back to top](#main-content)